Moderna chairman Noubar Afeyan said the company's COVID-19 vaccine candidate could enter midstage trials by spring or early summer. The vaccine started Phase I trials last month, and Moderna is already ramping up manufacturing capacity to allow production of millions of doses if the vaccine proves safe and effective.
Moderna's COVID-19 vaccine moves toward midstage trials
Sign up for AIChE SmartBrief
News for chemical engineers
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.